Stockscreener 앱 받기
24.49
0.12%
-0.03
시간 외 거래:
24.74
0.25
+1.02%
전일 마감가:
$24.52
열려 있는:
$24.66
하루 거래량:
509.20K
Relative Volume:
0.58
시가총액:
$2.76B
수익:
$14.09M
순이익/손실:
$-176.94M
주가수익비율:
-11.39
EPS:
-2.15
순현금흐름:
$-141.24M
1주 성능:
-8.96%
1개월 성능:
-2.31%
6개월 성능:
+4.93%
1년 성능:
+58.51%
1일 변동 폭
$24.36
$25.32
1주일 범위
$23.05
$27.35
52주 변동 폭
$14.06
$27.35
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
명칭
Newamsterdam Pharma Company Nv
전화
35 206 2971
주소
GOOIMEER 2-35, NARRDEN
NAMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
24.49 | 2.76B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-25 | 개시 | Wells Fargo | Overweight |
| 2025-07-17 | 개시 | Goldman | Neutral |
| 2025-06-17 | 개시 | Citigroup | Buy |
| 2025-06-10 | 개시 | Stifel | Buy |
| 2025-06-04 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-30 | 개시 | H.C. Wainwright | Buy |
| 2024-05-15 | 개시 | TD Cowen | Buy |
| 2024-03-14 | 개시 | Scotiabank | Sector Outperform |
| 2024-01-18 | 개시 | Guggenheim | Buy |
| 2024-01-16 | 개시 | Piper Sandler | Overweight |
| 2023-10-30 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Newamsterdam Pharma Company Nv 주식(NAMS)의 최신 뉴스
Topper James N, NewAmsterdam Pharma director, buys $15,638 in shares - Investing.com
Topper James N, NewAmsterdam Pharma director, buys $15,638 in shares By Investing.com - Investing.com UK
Recap Report: Will NewAmsterdam Pharma Company NV Equity Warrant stock hit new highs in YEARTrade Entry Report & Expert-Curated Trade Recommendations - خودرو بانک
Newamsterdam pharma CFO sells shares worth $1.5 million - MSN
Market Leaders: Is NewAmsterdam Pharma Company NV stock good for income investorsMarket Performance Recap & High Conviction Trade Alerts - خودرو بانک
Setup Watch: Should value investors consider NewAmsterdam Pharma Company N.V. Equity Warrant2025 Performance Recap & Growth Oriented Trade Recommendations - خودرو بانک
Published on: 2025-09-16 23:28:12 - خودرو بانک
Aug Highlights: Will NewAmsterdam Pharma Company NV outperform the market in YEARJuly 2025 Macro Moves & Weekly Return Optimization Plans - خودرو بانک
Stock Analysis: Is NewAmsterdam Pharma Company NV Equity Warrant exposed to political risk2025 Big Picture & Detailed Earnings Play Strategies - خودرو بانک
Retail Trends: Will NewAmsterdam Pharma Company N.V. Equity Warrant stock hit new highs in YEAR2025 Market WrapUp & Weekly Watchlist for Hot Stocks - خودرو بانک
Resistance Check: Will NewAmsterdam Pharma Company NV benefit from sector rotation2025 Growth vs Value & Risk Adjusted Buy and Sell Alerts - خودرو بانک
PTM Wealth Management LLC Takes $256,000 Position in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
Fred Alger Management LLC Sells 53,158 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
Market Fear: Will NewAmsterdam Pharma Company NV Equity Warrant benefit from AI trendsWeekly Market Summary & Fast Entry Momentum Trade Alerts - خودرو بانک
Tech Rally: Is Formula One Group stock showing strong momentumEntry Point & Expert Curated Trade Ideas - خودرو بانک
New Highs: What is Comcast Corporation’s valuation compared to sectorWeekly Trade Recap & Community Driven Trade Alerts - خودرو بانک
Revenues Not Telling The Story For NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) - 富途牛牛
Signal Recap: Can NewAmsterdam Pharma Company N.V. Equity Warrant sustain earnings growthJuly 2025 Rallies & Smart Allocation Stock Reports - خودرو بانک
Louise Frederika Kooij Sells 150,000 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock - MarketBeat
Woodline Partners LP Has $50 Million Stake in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma (NASDAQ:NAMS) Sets New 12-Month HighTime to Buy? - MarketBeat
NewAmsterdam Pharma (NASDAQ:NAMS) Sees Unusually-High Trading Volume on Insider Buying Activity - MarketBeat
NewAmsterdam Pharma (NASDAQ:NAMS) Trading Down 9.7% on Insider Selling - MarketBeat
Market reaction to NewAmsterdam Pharma Company N.V. Equity Warrant’s recent newsPortfolio Return Report & Detailed Earnings Play Alerts - Newser
Insider Buying: NewAmsterdam Pharma (NASDAQ:NAMS) Director Purchases 1,260 Shares of Stock - MarketBeat
Is it time to cut losses on NewAmsterdam Pharma Company N.V. Equity WarrantDip Buying & Advanced Swing Trade Entry Alerts - Newser
Risk vs reward if holding onto NewAmsterdam Pharma Company N.V. Equity WarrantRecession Risk & Safe Entry Trade Signal Reports - Newser
Alliancebernstein L.P. Acquires 383,888 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
What’s next for NewAmsterdam Pharma Company N.V. Equity Warrant stock price2025 Technical Patterns & Real-Time Buy Signal Notifications - Newser
When is the best time to exit NewAmsterdam Pharma Company N.V. Equity Warrant2025 Price Action Summary & High Return Trade Guides - Newser
NewAmsterdam Pharma Company N.V. stock outlook for YEAR2025 Analyst Calls & Capital Protection Trading Alerts - Newser
Leading vs lagging indicators on NewAmsterdam Pharma Company N.V. performanceEntry Point & Stepwise Trade Signal Implementation - Newser
What to expect from NewAmsterdam Pharma Company N.V. Equity Warrant in the next 30 daysRate Cut & Safe Entry Point Identification - Newser
What earnings revisions data tells us about NewAmsterdam Pharma Company N.V. Equity WarrantMarket Growth Report & Fast Momentum Stock Entry Tips - Newser
Technical signs of recovery in NewAmsterdam Pharma Company N.V. Equity Warrant2025 AllTime Highs & Advanced Swing Trade Entry Alerts - Newser
Analyzing drawdowns of NewAmsterdam Pharma Company N.V. with statistical toolsEarnings Miss & Expert Verified Movement Alerts - Newser
NewAmsterdam Pharma stock hits 52-week high at 27.35 USD By Investing.com - Investing.com Nigeria
Parkman Healthcare Partners LLC Purchases 24,839 Shares of NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma Company N.V.’s volatility index tracking explainedWeekly Stock Summary & Capital Efficient Trading Techniques - Newser
What candlestick patterns are forming on NewAmsterdam Pharma Company N.V.July 2025 Big Picture & Growth Focused Stock Reports - Newser
Trexquant Investment LP Invests $1.35 Million in NewAmsterdam Pharma Company N.V. $NAMS - MarketBeat
NewAmsterdam Pharma stock hits 52-week high at 27.35 USD - Investing.com
Newamsterdam Pharma CAO Kooij sells $3.8m in shares By Investing.com - Investing.com Australia
Topper, director at NewAmsterdam Pharma, buys $31,487 in shares By Investing.com - Investing.com South Africa
Topper, director at NewAmsterdam Pharma, buys $31,487 in shares - Investing.com India
Newamsterdam Pharma CAO Kooij sells $3.8m in shares - Investing.com
NewAmsterdam Pharma Company N.V. $NAMS Stock Holdings Lowered by Cutter Capital Management LP - MarketBeat
NewAmsterdam Pharma Company N.V. $NAMS Shares Bought by Adage Capital Partners GP L.L.C. - MarketBeat
NewAmsterdam Pharma Company N.V. Equity Warrant Stock Recovery Path — Analyst BreakdownJuly 2025 Update & Fast Momentum Entry Tips - beatles.ru
Resistance Break Could Fuel NewAmsterdam Pharma Company N.V. RallyJuly 2025 Spike Watch & Weekly Top Stock Performers List - beatles.ru
Newamsterdam Pharma Company Nv (NAMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.62%
0.57%
자본화:
|
볼륨(24시간):